Cargando…
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
BACKGROUND: In patients with peripheral arterial disease (PADs), who underwent percutaneous coronary intervention (PCI), little is known about the potential impact of using different new-generation drug-eluting stents (DES) on outcome. In PCI all-comers, the results of most between-stent comparisons...
Autores principales: | Pinxterhuis, Tineke H., Ploumen, Eline H., Zocca, Paolo, Doggen, Carine J. M., Schotborgh, Carl E., Anthonio, Rutger L., Roguin, Ariel, Danse, Peter W., Benit, Edouard, Aminian, Adel, van Houwelingen, K. Gert, Linssen, Gerard C. M., Geelkerken, Robert H., von Birgelen, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478025/ https://www.ncbi.nlm.nih.gov/pubmed/37675090 http://dx.doi.org/10.21037/cdt-22-584 |
Ejemplares similares
-
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
por: Zocca, Paolo, et al.
Publicado: (2018) -
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
por: Ploumen, Eline H., et al.
Publicado: (2021) -
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020) -
Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021) -
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)